🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the efficacy and safety of the combi...
Status
Completed
Location
University of South Alabama, Mitchell Cancer Institute ( Site 0065)
Start Date
2019-05-02
Trial ID
NCT03834506
Treatments Being Tested
Abbreviated Title: Neoadjuvant FOLFIRINOX combined with Pembrolizumab follo...
Status
Recruiting
Location
Baylor College of Medicine
Start Date
2022-08-31
Trial ID
NCT05132504
Treatments Being Tested
This phase I/II trial studies the side effects of gene-modified immune cell...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2019-07-03
Trial ID
NCT03747484
This clinical trial will evaluate a new combination of pembrolizumab, HPV-1...
Status
Completed
Location
UPMC Hillman Cancer Center
Start Date
2020-07-06
Trial ID
NCT04369937
Treatments Being Tested
Although immune checkpoint inhibitors (ICIs) have substantially extended su...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09
Trial ID
NCT07597070
Treatments Being Tested
The purpose of this research study is to evaluate the effectiveness of usin...
Status
Active Not Recruiting
Location
Indiana University Simon Comprehensive Cancer Center
Start Date
2022-09-02
Trial ID
NCT05366166
Treatments Being Tested
This study observes the antitumor activity, safety, tolerability, PK, and p...
Status
Terminated
Location
UC San Diego Moores Cancer Center
Start Date
2021-09-27
Trial ID
NCT04830124
The main aim of this study is to check if people with advanced solid tumors...
Status
Completed
Location
University of California San Diego Moores Cancer Center
Start Date
2020-07-22
Trial ID
NCT04420884
Treatments Being Tested
This is a parallel assigned, open-label, perspective trial studying the saf...
Status
Unknown
Location
Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University
Start Date
2022-05-20
Trial ID
NCT05339581
This phase II trial compares the effect of adding proton spatially fraction...
Status
Not Yet Recruiting
Location
Mayo Clinic in Rochester
Start Date
2026-09-07
Trial ID
NCT07783581